Age-related changes in the ability of hypothermia and cardioplegia to protect ischemic rabbit myocardium
- PMID: 3184966
Age-related changes in the ability of hypothermia and cardioplegia to protect ischemic rabbit myocardium
Abstract
Hypothermia combined with pharmacologic cardioplegia protects the globally ischemic adult heart, but this benefit may not extend to children; poor postischemic recovery of function and increased mortality may result when this method of myocardial protection is used in children. The relative susceptibilities to ischemia-induced injury modified by hypothermia alone and by hypothermia plus cardioplegia were assessed in isolated perfused immature (7- to 10-day-old) and mature (6- to 24-month-old) rabbit hearts. Hearts were perfused aerobically with Krebs-Henseleit buffer in the working mode for 30 minutes, and aortic flow was recorded. This was followed by 3 minutes of hypothermic (14 degrees C) coronary perfusion with either Krebs or St. Thomas' Hospital cardioplegic solution No. 2, followed by hypothermic (14 degrees C) global ischemia (mature hearts 2 and 4 hours; immature hearts 2, 4, and 6 hours). Hearts were reperfused for 15 minutes in the Langendorff mode and 30 minutes in the working mode, and recovery of postischemic function was measured. Hypothermia alone provided excellent protection of the ischemic immature rabbit heart, with recovery of aortic flow after 2 and 4 hours of ischemia at 97% +/- 3% and 93% +/- 4% (mean +/- standard deviation) of the preischemic value. Mature hearts protected with hypothermia alone recovered only minimally, with 22% +/- 16% recovery of preischemic aortic flow after 2 hours; none were able to generate flow at 4 hours. St. Thomas' Hospital solution No. 2 improved postischemic recovery of aortic flow after 2 hours of ischemia in mature hearts from 22% +/- 16% to 65% +/- 6% (p less than 0.05), but actually decreased postischemic aortic flow in immature hearts from 97% +/- 3% to 86% +/- 10% (p less than 0.05). To investigate any dose-dependency of this effect, we subjected hearts from both age groups to reperfusion with either Krebs solution or St. Thomas' Hospital solution No. 2 for 3 minutes every 30 minutes throughout a 2-hour period of ischemia. Reexposure to Krebs solution during ischemia did not affect postischemic function in either age group. Reexposure of immature hearts to St. Thomas' Hospital solution No. 2 caused a decremental loss of postischemic function in contrast to incremental protection with multidose cardioplegia in the mature heart. We conclude that immature rabbit hearts are significantly more tolerant of ischemic injury than mature rabbit hearts and that, unexpectedly, St. Thomas' Hospital solution No. 2 damages immature rabbit hearts.
Similar articles
-
Is protection of ischemic neonatal myocardium by cardioplegia species dependent?J Thorac Cardiovasc Surg. 1990 Feb;99(2):280-7. J Thorac Cardiovasc Surg. 1990. PMID: 2299865
-
The immature and the mature myocardium. Responses to multidose crystalloid cardioplegia.J Thorac Cardiovasc Surg. 1988 Apr;95(4):618-24. J Thorac Cardiovasc Surg. 1988. PMID: 3352295
-
Lowering the calcium concentration in St. Thomas' Hospital cardioplegic solution improves protection during hypothermic ischemia.J Thorac Cardiovasc Surg. 1991 Feb;101(2):314-25. J Thorac Cardiovasc Surg. 1991. PMID: 1992242
-
The role of magnesium in myocardial preservation.Magnes Res. 1995 Mar;8(1):85-97. Magnes Res. 1995. PMID: 7669511 Review.
-
Age-related differences in myocardial metabolism affects response to ischemia. Age in heart tolerance to ischemia.Am J Cardiovasc Pathol. 1992;4(2):175-80. Am J Cardiovasc Pathol. 1992. PMID: 1524800 Review.
Cited by
-
Coronary reserve and contractile reserve in crystalloid- and blood-perfused rabbit hearts.Heart Vessels. 1994;9(4):175-82. doi: 10.1007/BF01746061. Heart Vessels. 1994. PMID: 7961294
-
History and use of del Nido cardioplegia solution at Boston Children's Hospital.J Extra Corpor Technol. 2012 Sep;44(3):98-103. J Extra Corpor Technol. 2012. PMID: 23198389 Free PMC article.
-
Effects of pharmacological preconditioning by emodin/oleanolic acid treatment and/or ischemic preconditioning on mitochondrial antioxidant components as well as the susceptibility to ischemia-reperfusion injury in rat hearts.Mol Cell Biochem. 2006 Aug;288(1-2):135-42. doi: 10.1007/s11010-006-9129-3. Epub 2006 Apr 1. Mol Cell Biochem. 2006. PMID: 16583138
-
del Nido versus St. Thomas' blood cardioplegia in the young (DESTINY) trial: protocol for a multicentre randomised controlled trial in children undergoing cardiac surgery.BMJ Open. 2025 Apr 14;15(4):e102029. doi: 10.1136/bmjopen-2025-102029. BMJ Open. 2025. PMID: 40228861 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical